Financial Management Professionals »

Recursion Pharmaceuticals shares owned by Financial Management Professionals

Quarter-by-quarter ownership of Recursion Pharmaceuticals (RXRX) shares owned by Financial Management Professionals from 13F filings

Historical chart of Financial Management Professionals investment in Recursion Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Recursion Pharmaceuticals held by Financial Management Professionals consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Recursion Pharmaceuticals by Financial Management Professionals

Quarter filed Position value Share count Share price at filing
2024-03-31 $8.0k 840 9.52

More positions owned by Financial Management Professionals

Goldman Sachs Actvbeta US LRG ETF Etf (GSLC)
Schwab US Large Cap Growth ETF Etf (SCHG)
John Hancock Multifctr Mid CP ETF Etf (JHMM)
Goldman Sachs Actvbt Intereqy ETF Etf (GSIE)
iShares Russell 1000 ETF IV Etf (IWB)
iShares MSCI USA Multifct ETF Etf (SMLF)
JPMorgan Ultra Short Income ETF Etf (JPST)
Vanguard S&P 500 ETF Etf (VOO)
Vanguard Total Bond Market ETF Etf (BND)
Schwab US Large Cap ETF Etf (SCHX)
PIMCO 0-5 Year High YLD BND Idx ETF Etf (HYS)
SPDR BLMBG SRT TR Int TRY BND ETF Etf (BWZ)
Schwab International Equity ETF Etf (SCHF)
Fidelity High Yield Factor ETF Etf (FDHY)
Vanguard Large Cap ETF Etf (VV)

View all positions for Financial Management Professionals

Top funds holding Recursion Pharmaceuticals

ARK Investment Management
Baillie Gifford & Co
Vanguard Group
Mubadala Investment Co PJSC
Kinnevik AB
Sumitomo Mitsui Trust Holdings
Nikko Asset Management Americas
MIC Capital Management UK
Nvidia Corp
Norges Bank Investment Management
Dimensional Fund Advisors
Credit Suisse
Point72 Asset Management
Goldman Sachs Group
Charles Schwab Investment Management

View all funds holding Recursion Pharmaceuticals